Atlas Trials

Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)

Clinical trial NCT01947309 · TERMINATED

Trial details

NCT number
NCT01947309
Sponsor
Celgene
Status
TERMINATED
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2013-11-01
Primary completion
2016-07-01
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.